Latest Concord Biotech News | Concord Biotech News | Concord Biotech Funding | Concord Biotech Fund - vccircle
Advertisement

Concord Biotech

Premium
Quadria Capital set to finish returning first fund, eyes new vehicle's first close

Finance

28 August, 2023

Quadria Capital set to finish returning first fund, eyes new vehicle's first close

Quadria Capital, a healthcare-focused investor, has started distributing the gains from its 10-year -old first fund, along with the principal, ......

Concord Biotech gains 27% on stock market debut as valuation tops $1 bn

Healthcare

18 August, 2023

Concord Biotech gains 27% on stock market debut as valuation tops $1 bn

Concord Biotech, a pharmaceutical ingredients maker, made a strong stock market debut on Friday with its shares listing at a ......

Premium
Quadria set to score another modest exit from India portfolio

Healthcare

31 July, 2023

Quadria set to score another modest exit from India portfolio

Quadria Capital, a healthcare-focused private equity firm that recently committed around $158 million to GSK Velu-led eyecare chain Maxivision Eye Hospital, is looking at ......

Premium
Grapevine: Warburg eyes Brookfield's IT services bet; Concord, Manappuram arm gear up for IPOs

General

28 July, 2023

Grapevine: Warburg eyes Brookfield's IT services bet; Concord, Manappuram arm gear up for IPOs

Private equity firm Warburg Pincus is in advanced talks to acquire an IT services business owned by Brookfield Asset Management, ......

Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO

Healthcare

17 August, 2022

Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO

Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital ......

Quadria Capital to sell stake in API maker Concord Biotech

Healthcare

15 August, 2022

Quadria Capital to sell stake in API maker Concord Biotech

Healthcare-focused private equity fund Quadria Capital will sell its entire 20% stake in active pharmaceutical ingredients maker Concord Biotech in ......

Premium
Quadria Capital-backed Concord Biotech Pvt pivots to IPO, appoints banker

Healthcare

10 September, 2021

Quadria Capital-backed Concord Biotech Pvt pivots to IPO, appoints banker

Quadria Capital-backed Concord Biotech has appointed a merchant bank as it moves a step forward towards raising capital via a ......

Premium
Quadria Capital preparing to exit biotech firm

Healthcare

21 April, 2021

Quadria Capital preparing to exit biotech firm

India and Southeast Asia-focused Quadria Capital is preparing to exit a biotech portfolio firm as deals in the broader pharmaceuticals ......

Premium
Quadria Capital hits the road for new healthcare PE fund

Healthcare

06 August, 2018

Quadria Capital hits the road for new healthcare PE fund

Quadria Capital, a private equity firm which focuses on South- and Southeast Asia, has hit the road to raise its ......

Premium
Kedaara Capital scraps talks to buy into RG Stone; other PE firms in fray

Healthcare

22 September, 2016

Kedaara Capital scraps talks to buy into RG Stone; other PE firms in fray

Private equity firm Kedaara Capital has called off negotiations to acquire India Equity Partners’ (IEP) stake in RG Stone Urology ......